# FDA Inspection 1235608 - Tianjin Jinjin Pharmaceutical Co. Ltd. - March 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/tianjin-jinjin-pharmaceutical-co-ltd/5bd16620-3d77-4db2-8032-57e6f789f62f
Source feed: FDA_Inspections

> FDA Inspection 1235608 for Tianjin Jinjin Pharmaceutical Co. Ltd. on March 29, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1235608
- Company Name: Tianjin Jinjin Pharmaceutical Co. Ltd.
- Inspection Date: 2024-03-29
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 990272 - 2016-09-09](https://www.keypedia.com/records/fda_inspections/tianjin-jinjin-pharmaceutical-co-ltd/0bf0e4bf-adab-4f29-a1f6-c7f30947cf2f)
- [FDA Inspection 734344 - 2011-06-17](https://www.keypedia.com/records/fda_inspections/tianjin-jinjin-pharmaceutical-co-ltd/0a33713f-922a-4c40-9f7f-c12a31852723)

Company: https://www.keypedia.com/companies/tianjin-jinjin-pharmaceutical-co-ltd/53d9554b-4bbf-4e1a-a625-83cd0aceafba

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c